Policy

In a recent podcast appearance, the billionaire former member of “Shark Tank” ripped into insurance companies and defended physicians.

Strategies to ensure health equity were the subject of a panel discussion at the ACP Internal Medicine Meeting 2025 in New Orleans.

Leah Binder, president and CEO of The Leapfrog Group, discusses the organization’s 25th anniversary and more.

Physicians Advocacy Institute publishes figures on five-year decline.

Leah Binder, president and CEO of The Leapfrog Group, discusses the organization’s 25th anniversary and more.

The time is now to create an action plan that fits your practice when it comes to cutting costs and raising revenue streams. Read Medical Economics Insider to get started.

Between President Trump's tariff plan and sweeping layoffs at the FDA and HSS, the medical device industry is facing an uncertain future.

The evolving landscape of Medicaid work requirements

Leah Binder, president and CEO of The Leapfrog Group, discusses the organization’s 25th anniversary and more.

How will federal leadership and employment changes affect the American health care system?

‘The revolution begins today,’ new HHS Secretary RFK Jr. says.

Merged organizations pledge to advance innovative technologies to improve patient care.

In many states, nurse practitioners are gaining greater permission to practice and prescribe independently, with varying levels of physician oversight. What do physicians think of this trend? See our exclusive physician survey results to find out.

Introducing the inaugural issue of Medical Economics Insider, featuring practical tips and expert interviews on medical practice finance, plus exclusive survey data on how physicians feel about nurse practitioner independence.

Nearly 1,900 of the nation’s top scientists warn that funding cuts and censorship put medical advances at risk.

Meanwhile, FTC members contest removal by Trump.

Leading medical organizations warn that workforce reductions could disrupt public health and patient care.

Fed’s key inflation measure showed the biggest monthly gain since January 2024

Imported components account for almost half of US companies’ FDA-approved products

Secretary Kennedy’s plan consolidates 28 divisions, forms a new health agency and shifts focus to chronic disease prevention.

Media report highlights how FDA workloads have increased, and delays for new technology approvals will likely suffer

Coming March 31 to MedicalEconomics.com.

As obesity medications gain popularity, many older Americans support coverage — but not higher premiums.

Policy center argues patients around the world benefit when Americans pay more than their fair share for research and medicines.

Finance Committee ready to send nomination to full Senate, ranking member says.

A new JAMA study shows preventable deaths rising in every U.S. state, defying global progress.

As business and administrative challenges continue to mount — from declining reimbursement rates to increased competition — our mission is to deliver timely content that helps you run your practice more effectively. Enter Medical Economics Insider.

ACP, medical groups, and Sen. Cassidy challenge the Louisiana Surgeon General’s decision.

Public health experts describe the latest on measles cases in Texas and broader concerns about vaccinations.

ACA provisions boost primary care training amid worsening physician shortage.